FIND

Nearly 75% of deaths worldwide are caused by non-communicable diseases (NCDs) such as diabetes, hypertension, chronic kidney disease and cardiovascular conditions. NCDs represent the leading drivers of premature deaths worldwide. Early detection and management of NCDs is essential to prevent long-term complications, save lives, and reduce the economic burden on families and health systems. At FIND we are working towards reducing deaths from NCDs in low-and middle-income countries (LMICs) by strengthening primary healthcare. By uniting patients, clinicians, innovators, and manufacturers, we address critical access barriers to essential diagnostics. Through the ACCEDE project (https://lnkd.in/etkGPZbr), we are building critical capacity and evidence for the integration of continuous glucose monitoring (CGM) into public healthcare systems - alongside free online training for both providers and people living with diabetes. More recently, FIND conducted a landscape analysis of point-of-care creatinine tests to evaluate available technologies for decentralized management of chronic kidney disease in primary healthcare settings.  Our efforts focus on generating evidence to inform WHO guidance, assessing innovations for market fit, and strengthening the capacity of health workers, systems, and communities. This Global Week for Action on NCDs, we highlighted a critical barrier in the response to NCDs: access to early diagnosis. How is your organization helping to bridge the NCD diagnostic gap? Join the conversation and tell us in the comments below. NCD Alliance, Health Action International, The Helmsley Charitable Trust, Mark Barone, PhD, International Diabetes Federation Dr. Priyanka Singh, Cathy HALDANE #DiagnosisForAll #ActOnNCDs #NCDs #UniversalHealthCoverage #HealthEquity 

➡️ FIND’s abstract: “From Months to Days: How Community Leadership Transformed Hepatitis C Care for People who inject drugs (PWIDs)” has been selected for the 12th International Viral Hepatitis Elimination Meeting (IVHEM)2026 (https://lnkd.in/ep9MUbRX) taking place today and tomorrow in Hiroshima, Japan. Read more to learn how operational bottlenecks to hepatitis care can be reduced by embedding lived experience into programme design and empowering communities as equal partners. Abstract available on page 37 of the official abstract book 📖 https://lnkd.in/ehSenG9Y Dr Sarabjit Chadha Dr Kanudeep Kaur #DiagnosisForAll #IVHEM2026 #HepatitisElimination #GlobalHealth #ViralHepatitis #HepatitisB #HepatitisC

FIND is deeply saddened by the passing of Dr Vasee Moorthy, Senior Science and Strategy Advisor and acting Lead of the R&D Blueprint for Epidemics at WHO. His loss will be felt deeply by colleagues and partners across the global health community. Over the years, our teams had the privilege of working with Dr Moorthy on several occasions. We will remember him not only for his scientific rigour and remarkable contributions to infectious disease research and clinical trials, but also for his generosity, collaborative spirit and unwavering commitment to improving health for people everywhere. We were especially grateful for the opportunity to collaborate with him during the development of the WHO TB sequencing knowledgebase, where he brought thoughtful leadership to important discussions on data governance and ownership. We extend our heartfelt condolences to Dr Moorthy’s family, friends and colleagues at WHO. Together with the many people whose lives and work he touched, we honour his memory and the remarkable legacy he leaves behind.

FIND has contributed to findings from the ACCISS (Challenge and Constraints of Insulin Sources and Supply) study report, led by Health Action International, which focuses on identifying and tackling global insulin market inequities and inefficiencies.   This Global Week for Action on NCDs is a reminder that regular glucose monitoring is essential for effective diabetes management, however only a fraction of people in low- and middle-income countries (LMICs) can routinely self-monitor.   Let's #ActOnNCDs together to change this. Don’t miss their findings! Dr. Priyanka Singh Cathy HALDANE Beatrice Vetter PhD

➡️ How can we expand sustainable access to life-saving HPV DNA testing for more women? With support from FIND, the Hai Phong Department of Health, Viet Nam, developed a co-payment model based on scientific evidence, policy frameworks, and local implementation capacity offering a roadmap for scalable cervical cancer screening. Key highlights of the model: -Connects commune/ward health stations with the CDC via primary healthcare software, keeping testing close to home while maintaining quality and care coordination. -Proposes a maximum 50% individual co-payment with flexible screening targets based on municipal budget capacity. -Every 1 VND invested is estimated to return 6.78 to 8.01 VND in benefits by preventing hundreds of cervical cancer cases and deaths over ten years. -Blends local government support with individual contributions to ensure long-term financial health. -Leverages trusted networks like the Labour Union, Women’s Union and health worker networks to build trust and boost participation.    This model provides a practical, evidence-backed pathway to bridge gaps in screening.  Learn more 📽️ https://lnkd.in/eCqkgpnC

📢 FIND recently joined partners in Rio de Janeiro at the closing event of CUIDA Chagas – an initiative led by Fundação Oswaldo Cruz (Fiocruz) alongside the National Institute of Health Laboratories (INLASA), from Bolivia; the National Health Institute (INS), from Colombia; and the National Malaria Eradication Service (SENEPA), from Paraguay. Since 2021, with support from Unitaid and the Ministry of Health of Brazil, CUIDA Chagas has worked to revolutionize Chagas care. As a consortium partner, FIND contributed by providing technical support to INLASA and Fiocruz to validate decentralized, point-of-care diagnostic models, while driving regional efforts across all four countries to strengthen supply chains and ensure equitable access to innovative diagnostics. The event provided an opportunity to engage with representatives from ministries of health across the consortium, and to reflect on the capacity strengthened through CUIDA Chagas and the impact of its activities. Together participants explored how the project's key recommendations including those informed by new clinical evidence and supply chain interventions can be embedded in national systems and sustained beyond the project’s lifetime. The meeting was a valuable opportunity to re-connect with partners, learn from community members affected by Chagas, and celebrate the incredible progress achieved together 🎉 Although this phase of the project is drawing to a close, our shared mission continues. We aim to continue working across Latin America for a more equitable response to Chagas disease. Thank you to the FIND team and all our partners for their expertise and dedication to this initiative 🤝 #DiagnosisForAll #CUIDAChagas #ChagasDisease #Diagnostics #GlobalHealth #HealthEquity #LatinAmerica 

Protecting pregnant and breastfeeding women starts with generating the evidence they deserve 👇 For too long, pregnant and breastfeeding women have been excluded from clinical research, leaving critical gaps in the evidence needed to guide the safe and effective use of medicines and diagnostics. As a result, healthcare providers are often forced to make decisions without the data needed to deliver the best care. FIND represented by Elvis Safary, PhD joined the Collaborative Group on Global Maternal and Child Health in calling for the implementation of the International Council for Harmonisation (ICH) E21 draft guideline. Moving from guidance to action means ensuring that pregnant and breastfeeding women are appropriately included in research and clinical trials, so that lifesaving innovations including diagnostics are developed, evaluated, and made accessible for those who need them most. Better evidence leads to better decisions. Better diagnostics lead to better outcomes for women, newborns, and families. Read the publication: https://rdcu.be/fxZHs #DiagnosisForAll #MaternalHealth #WomensHealth #ClinicalResearch #HealthEquity #ICH21

Today is #WorldMosquitoDay. Meet Anopheles — the mosquitoes that transmit the parasites causing malaria. Only the female bites.   Malaria kills around 600,000 people a year — almost all in sub-Saharan Africa, most of them children under five.   What surprises most people: Malaria occurred in Switzerland’s Rhine and Limmat valleys and near Lakes Zurich and Lucerne until the mid-20th century. Anopheles mosquitoes are still present in Switzerland today. What disappeared was the parasite. Drainage, DDT, improved housing and treatment together broke the transmission chain.   Curious about the other mosquito — the one that bites in broad daylight? 👉 Follow Swiss Alliance against Neglected Tropical Diseases (SANTD) this week.   #Malaria #Anopheles #SwitzerlandForGlobalHealth

Last week, FIND and the Metropolitan Surveillance Unit (Patna Municipal Corporation, Bihar, India) hosted a One Health integration and sensitization workshop. The MSU serves a population of 2.5 million people and the workshop in Patna was organized under the leadership of Shri Yashpal Meena, Municipal Commissioner (I.A.S) bringing together stakeholders from the human, animal, and environmental health sectors to strengthen collaboration for disease surveillance and outbreak preparedness. Cities like Patna, Bihar face numerous public health challenges, often compounded by fragmented surveillance systems, disconnected reporting mechanisms, and limited coordination across human, animal, and environmental health sectors. FIND is supporting efforts to strengthen diagnostic and surveillance architecture, enabling a more integrated One Health approach and helping the city detect, understand, and respond to health threats more effectively. The workshop focused on key areas including: ➡️ Integrated disease surveillance & health information platform (IHIP) reporting ➡️ Laboratory surveillance and diagnostic network integration ➡️ One Health and AMR surveillance, including WHONET reporting ➡️ Antimicrobial stewardship ➡️ Zoonotic disease and veterinary AMR surveillance ➡️ Environmental surveillance and intersectoral coordination The workshop was inaugurated by the Honorary Mayor of Patna - Shrimati Sita Sahu. We were privileged to have Dr. Shubhangi Kulsange, Joint Director & Nodal Officer and Dr Simmi Tiwari, Joint Director & Officer-in-Charge from the National Centre for Disease Control (NCDC), a premier institute for research, surveillance, and control of communicable diseases, under the Ministry of Health and Family Welfare, Government of India join virtually and share valuable insights on strengthening integrated surveillance systems and zoonosis in One Health. Participants included senior officials from the health, animal husbandry, and environmental sectors. Representatives from private hospitals and diagnostic laboratories also actively participated, reflecting the importance of a truly multisectoral approach. Discussions underscored the need for stronger coordination, information sharing, and integrated surveillance mechanisms to enable early detection, timely response, and resilient public health systems. The workshop reaffirmed a collective vision for building a future-ready disease surveillance ecosystem in Bihar, where human, animal, laboratory, and environmental health systems work together seamlessly. Special thanks to Dr Arindam Ray of the Gates Foundation for his presence and overall guidance. Dr Sarabjit Chadha, Dr Ranjit Kumar (MSU), Dr. Navneet Ranjan, Dipen Desai, Ranjana Upadhyay, Annie Misra, Rahul Shrivastav, Dr. Tanvi Behl Bhalla, and Ajay Deepak Sehgal. #DiagnosisForAll #OneHealth #DiseaseSurveillance #PublicHealth #MSUBihar #Patna #OutbreakPreparedness #HealthSecurity #NCDC #IHIP